Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Duloxetine in Diabetic Peripheral Neuropathic Pain
NCT05292066Phase 1Unknown
- Sponsor
- Aga Khan University
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial in diabetic polyneuropathy (DPN) comparing Duloxetine Group with Pregabalin Group (2 arms). Primary endpoints: Visual Analogue Scale at 3 months and Toronto Clinical Neuropathy Score at 3 months. Status: unknown.
02
Drugs
duloxetinepregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT05292066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292066.